Send to

Choose Destination
See comment in PubMed Commons below
Circulation. 2004 Sep 7;110(10):1326-9. Epub 2004 Jul 12.

gp91phox-dependent expression of platelet CD40 ligand.

Author information

  • 1Divisione IV Clinica Medica, Dipartimento di Medicina Sperimentale e Patologia, Universit√† di Roma La Sapienza, Policlinico Umberto I, 00185, Rome, Italy.



CD40 ligand (CD40L) expression on platelets is mediated by agonists, but the underlying mechanism is still unclear.


CD40L expression was measured in platelets from healthy subjects both with and without the addition of antioxidants or a phospholipase A2 (PLA2) inhibitor and in platelets from 2 patients with an inherited deficiency of gp91phox. Immunoprecipitation analysis was also performed to determine whether normal platelets showed gp91phox expression. Unlike catalase and mannitol, superoxide dismutase inhibited agonist-induced platelet CD40L expression in healthy subjects. Immunoprecipitation analysis also showed that platelets from healthy subjects expressed gp91phox. In 2 male patients with inherited gp91phox deficiency, collagen-, thrombin-, and arachidonic acid-stimulated platelets showed an almost complete absence of superoxide anion (O(2)(-)) and CD40L expression. Incubation of platelets from healthy subjects with a PLA2 inhibitor almost completely prevented agonist-induced O(2)(-) and CD40L expression.


These data provide the first evidence that platelet CD40L expression occurs via arachidonic acid-mediated gp91phox activation.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk